Acute kidney injury (AKI) is one of the most common renal disorders leading to significant morbidity and mortality. Unfortunately, strategies to prevent or treat AKI are lacking. In recent years, a series of preconditioning protocols has been shown to be effective in inducing organ protection in rodent models. Here, we characterized two of these interventionscaloric restriction and hypoxic preconditioningin a mouse model of cisplatin-induced AKI and investigated the underlying mechanisms by acquisition of multi-layered omic data (transcriptome, proteome, N-degradome and membrane lipidome) and functional parameters in the same animals. Both preconditioning protocols markedly ameliorated cisplatin-induced loss of renal function. Bioinformatic analysis revealed mRNA-independent proteome alterations affecting the extracellular space, tubule mitochondria and transporters. Interestingly, our analyses revealed a strong dissociation of protein and RNA expression after cisplatin treatment that showed a strong correlation with the degree of damage across the cohort. N-degradomic analysis revealed that most posttranscriptional changes were determined by Arg-specific proteolytic processing. This included a characteristic cisplatinactivated complement signature that was prevented by preconditioning. In addition, amyloid and acute-phase proteins accumulated within the cortical parenchyma. Extensive analysis of disease associated molecular patterns suggested that transcription-independent deposition of amyloid P-component serum protein may be a key component in the microenvironmental contribution to kidney damage. In conclusion, this proof-of-principle study provides new insights into the pathogenesis of cisplatin-induced AKI and the molecular mechanisms underlying organ protection by the means of multi-omic-phenotype correlations. 4 Introduction.
Abstract.
Acute kidney injury (AKI) is one of the most common renal disorders leading to significant morbidity and mortality. Unfortunately, strategies to prevent or treat AKI are lacking. In recent years, a series of preconditioning protocols has been shown to be effective in inducing organ protection in rodent models. Here, we characterized two of these interventionscaloric restriction and hypoxic preconditioningin a mouse model of cisplatin-induced AKI and investigated the underlying mechanisms by acquisition of multi-layered omic data (transcriptome, proteome, N-degradome and membrane lipidome) and functional parameters in the same animals. Both preconditioning protocols markedly ameliorated cisplatin-induced loss of renal function. Bioinformatic analysis revealed mRNA-independent proteome alterations affecting the extracellular space, tubule mitochondria and transporters.
Interestingly, our analyses revealed a strong dissociation of protein and RNA expression after cisplatin treatment that showed a strong correlation with the degree of damage across the cohort. N-degradomic analysis revealed that most posttranscriptional changes were determined by Arg-specific proteolytic processing. This included a characteristic cisplatinactivated complement signature that was prevented by preconditioning. In addition, amyloid and acute-phase proteins accumulated within the cortical parenchyma. Extensive analysis of disease associated molecular patterns suggested that transcription-independent deposition of amyloid P-component serum protein may be a key component in the microenvironmental contribution to kidney damage. In conclusion, this proof-of-principle study provides new insights into the pathogenesis of cisplatin-induced AKI and the molecular mechanisms underlying organ protection by the means of multi-omic-phenotype correlations.
Introduction.
Acute kidney injury (AKI) is one of the most common complications in hospitalized patients and shows a rapidly increasing incidenceespecially in the elderly 1, 2 . Although partial recovery occurs in the majority of patients, AKI is strongly associated with prolonged hospitalization, increase of mortality and progression to end-stage renal disease (ESRD) [3] [4] [5] [6] [7] .
ESRD can also be the consequence of recurrent, minor episodes of AKI during lifetime 8 . AKI is associated with financial burden to modern healthcare systems exceeding an estimate of 10 billion dollars per year in the US 7, 9, 10 . While pre-or postrenal AKI can be detected and treated rather readily, the actual cellular damage of kidney tissue (intrarenal AKI) is the major determinant of outcome. Several key factors causing intrarenal AKI are known, among these ischemia-reperfusion during injury surgery, and nephrotoxic agent exposure. However, targeted ways to prevent this damage are still not available.
In 1986 Murry et al. showed that the exposure of the myocardium to sublethal levels of ischemia can protect animals from consecutive myocardial infarctiona concept called ischemic preconditioning 11 . This effect is not limited to the heart but can also be exploited in other organs such as the kidney 12 . Since then, several renal preconditioning interventions have been characterized primarily in rodent models. Two prominent examples are caloric restriction (CR) and hypoxic preconditioning (HP) that showed substantial protective potential for AKI [13] [14] [15] . Unfortunately, these strategies have not made their way to clinical application so far due to problems with feasibility on the one hand but also reproducibility in the much more complex setting of patients' care on the other hand. Consequently, a more profound knowledge of the molecular key changes in different forms of AKI and the molecular mechanisms underlying preconditioning-mediated organoprotection is essential to uncover refined therapeutic targets in patients.
Here, we demonstrate that hypoxic preconditioning and caloric restriction can be both utilized to prevent intrarenal damage inflicted by nephrotoxic treatment in mice. We then applied multi-layered omics approach to investigate the molecular composition of a protected damaged versus an unprotected damaged kidney to prioritize the most important molecular patterns associated with renal damage. Transcriptomic (mRNAseq) and proteomic analyses revealed a strong dissociation of protein and RNA expression after AKI correlating with the severity of injury. N-Degradomic analyses exposed that most posttranscriptional changes were determined by serine protease-dependent proteolytic processing, including a characteristic complement activation signature.
Results.
To induce acute kidney injury we applied an intraperitoneal bolus of cisplatin to untreated wildtype mice (cis, Fig. 1A ). At the same time, we administered cisplatin to mice either preconditioned by caloric restriction 13 (CR, only 66 % of the averaged daily intake of calories for 28 days) or by incremental hypoxia 16 (HP, 8.3 % O2 for 2/4/8 h on three following days) ( Fig. 1A) . Compared to vehicle treated mice (veh), cisplatin treated mice (cis) showed a significant weight loss after 72 h hours (one-way ANOVA and Bonferroni's Multiple Comparison Test p-value < 0.001). Calorically restricted (CR) and hypoxia (HP) treated animals did not lose weight significantly 72 h after AKI (Fig. 1B, Fig. S1A ) (one-way ANOVA and Bonferroni's Multiple Comparison Test p-value < 0.05). Consistent with a protective effect of our preconditioning strategies, blood urea nitrogen (BUN) and plasma creatinine were significantly higher in non-preconditioned animals after cisplatin administration than in preconditioned animals ( Fig. 1C, D) . Plasma values of creatinine and BUN showed a strong correlation with plasma values of Cystatin C in a different cohort supporting the loss of kidney function due to cisplatin treatment and prevention by preconditioning ( Fig. S2 ). Histologically, kidneys of cisplatin treated control mice showed a significant deposition of PAS positive material in the interstitium (Fig. 1E ). In addition, nuclear pyknosis indicative of cell death and intratubular protein casts were observed in the kidneys treated with cisplatin. In hypoxia treated animals (HP), kidneys showed a significantly better histological appearance with less nuclear pyknosis and less casts. Calorically restricted (CR) mice showed a histological outcome after cisplatin treatment, which was not notably different from kidneys obtained from vehicle treated animals ( Fig. 1E ). Semi-quantitative analysis of histological damage showed a protective effect, particularly in CR animals ( Fig. S3A ). To further validate histological damage we have also included immunostainings of KIM1, a marker for renal damage 17 , that suggested a stronger renal damage in cis > HP > CR > veh ( Fig. S3B ). Analysis of regulated cell death as determined by TUNEL assay demonstrated a high number of TUNEL positive cells in the kidneys of animals only treated with cisplatin, significantly less after hypoxic preconditioning and none in calorically restricted or vehicle treated animals ( Fig. 1F ). These results demonstrate that preconditioning interventions have the potential to ameliorate cisplatin-induced intra-renal damage.
In order to characterize the molecular changes induced by cisplatin-toxicity and their modulation by preconditioning we performed quantitative label-free proteomic analysis of the renal cortices of the same mice we used for the analyses mentioned above and identified more than 6000 proteins. 4733 proteins could be identified across all samples -(see methods for details, see table S1 for detailed results). Using hierarchical clustering for Euclidean distance, we found a clear separation between vehicle treated and cisplatin treated kidneys ( Fig. 2A ). We also found that in principal component analysis (PCA), cisplatin and vehicle treated samples were clearly distinguishable. In contrast, proteomic profiles of vehicle and cisplatin treated kidneys after caloric restriction were very similar ( Fig. 2B ). Then we analyzed the effect of cisplatin on kidney tissue as compared to vehicle treatment.
Comparison of protein abundance between both conditions with stringent parameters (s0=0.1 and FDR <0.01) identified 1448 significantly changed proteins. 636 proteins were increased, and 812 were decreased after cisplatin treatment (Fig. 2C ). We found many proteins known to increase with acute kidney injury, among these Ngal (gene symbol: Lcn2 18 ) and alpha fetuin-a (gene symbol: Ahsg 19 ). A GO term enrichment (FDR = 0.02) analysis revealed, that proteins related to extracellular matrix and acute phase reaction were increased after cisplatin exposure, consistent with an inflammatory and fibrotic response in the tissue (Fig. 2D ). Moreover, proteins associated with transmembrane receptor protein kinase activity were increased, consistent with protein alterations affecting intracellular response machineries ( Fig. 2D ). Conversely, proteins associated with the excretion of ions, amino acids and metabolites were decreased in the dataset, as well as proteins associated with mitochondria ( Fig. 2D ).
"Extracellular matrix" is an ambiguous term in which multiple biological entities are lumped together (e.g. secreted proteins and known basal lamina and "matrisome" associated proteins) 20, 21 . Among the upregulated proteins, we found core matrisome proteins, but also secreted matrisome associated proteins as well as secreted proteins not related to the matrisome (e.g. amylase, lysozyme and others, Fig. 2E ). Among these secreted proteins, we found an increase in particular smaller proteins that are more easily filtered and taken up by endocytic mechanisms in the proximal tubule 22 (Fig. 2F ).
Next, we performed hierarchical clustering analyses to define global proteomic shifts across the four treatment groups (Fig. 3A ). 6 major clusters, each with more than 10 proteins, could be defined ( Fig. 3B ). Three clusters had protein patterns increasing with extent of damage (protein expression veh < CR < HP < cis). These clusters were significantly enriched for several distinct processes such as complement, extracellular matrix generation, and chemotaxis ( Fig. 3C ). One cluster showed a decreased protein expression with the extent of damage (protein expression veh > CR > HP > cis). This cluster was largely enriched for transmembrane proteins and proteins involved in proximal tubule function such as sodium transport and amino-acid transport. One cluster containing 13 proteins (cluster 5) peaked specifically in kidneys of CR preconditioned animals, which were almost completely protected from cisplatin induced damage. This cluster was enriched for proteins involved in fatty acid biosynthesis, indicating that the induction of these proteins may be involved in the protective capacity of caloric restriction.
To further investigate whether these changes were relevant, we performed targeted lipidomic analysis by Nano-Electrospray Ionization Tandem Mass Spectrometry with direct infusion of lipid extracts from treated mouse kidneys (Shotgun Lipidomics) . The levels of   different  glycerophospholipid  subspecies  (phosphatidylcholins,  PC, phosphatidylethanolamines, PE, phosphatidylinositols, PI, phosphatidylserines, PS) were determined by lipid class-specific neutral loss and multiple precursor ion scanning (for detailed results, see suppl . table S2 ). This analysis revealed a loss of membrane lipids during cisplatin induced injury. This loss of lipids was lower after CR suggesting that a loss of membrane integrity is associated with cisplatin induced injury, which can be abolished by CR ( Fig. 3D ).
Prominent alterations in mRNA expression have been determined by high-throughput
analyses of kidneys after the induction of different modes of AKI 23 . Yet, mRNA expression does not necessarily and always predict protein abundance 24 . Thus, we asked whether the extent of dysregulated proteins was largely due to the expression of altered transcripts. To this end, we performed analyses of the transcriptome from the same kidneys as used for the proteomics analyses using next generation sequencing (NGS)see table S3 for detailed results. Employing t-SNE clustering of the individual transcript levels, we found that samples of vehicle treated (veh) mice and samples of cisplatin treated mice after caloric restriction (CR) were closely related and both showed similar differences in comparison to the samples of unpreconditioned cisplatin treated animals (cis), consistent with our proteome data ( Fig.   4A ). Of note, the fold-changes (e.g. in cis vs veh) were less prominent as determined by proteomics analysis (Fig. S4A, B ). Enrichment analysis determined similar pathways being regulated as compared to the proteome (Fig. S4C , D). Next, we performed a correlative analysis between mRNA and protein copy number level for every individual protein-mRNA pair. The distribution of mRNA-protein correlation coefficients of all individual protein-mRNA correlation coefficients revealed that transcript copy numbers only moderately determined protein abundance in all treated samples ( Fig. 4B ) as commonly observed 25 . Interestingly, when analyzing each treatment group separately, we found that correlation between transcripts and proteome levels was highest in CR ( Fig. 4C ) (R = 0.57), significantly lower in HP (R = 0.54) and much lower in cis (R = 0.47). To examine the relationship of a low correlation coefficient of the transcriptome and proteome and the severity of kidney damage, we plotted the correlation coefficient against the individual creatinine value in every mouse analyzed. Notably, we observed a very strong and significant connection between the correlation coefficient R and log 2 (creatinine), R = -0.98 ( Fig. 4D ), that could also be recapitulated by usage of the values for BUN (R = -0.96) ( Fig. 4 E) . Both creatinine and BUN showed strong correlations with Cystatin C (Fig. S2 ), which is another well-known biomarker for AKI 17 . The connection between the correlation coefficient R and log 2 (creatinine) suggested that -with increased severity of kidney damage -transcriptomic data becomes less predictive of protein abundance indicating that posttranscriptional changes must play an important role in the response to injury.
Posttranslational regulatory mechanisms, such as proteolytic cleavage reactions by proteases or the proteasome, have been described as a major regulator of the posttranscriptional landscape in different scenarios of cell death, including AKI 26, 27 . Mass spectrometry-based N-degradomics enables identification and quantification of protein Ntermini and proteolytic activity on a proteome-wide scale [28] [29] [30] . We used the established indicating increased proteolytic activity in damaged kidneys. Analysis of positional amino acid frequency matrices (motifs) can be used to infer dominant proteolytic activities 30 . Here, motif analysis showed that in the CR experiment, cisplatin treatment increased mainly termini starting with S or T predominantly resulting from cleavage after a basic residue (K, R and H; Fig. 5C ). This was also found in the HP dataset ( Fig. 5D ), suggesting a cisplatin-induced activity of arginine and lysine-specific proteases such as trypsin-like serine proteases. To test whether these alterations were independent of total proteome changes, we tested whether total proteome fold changes in cisplatin-induced damage correlated with the fold change of the respective cleavage sites within the protein. We observed a strong and very significant correlation between proteome expression and N-termini abundance ( Fig. 5E ), indicating that also cleaved fragments abundance largely reflected protein abundance. Consistently, we found that there was a very weak negative correlation between N-termini abundance and the protein-mRNA correlation coefficient described above ( Fig. S5C ). Interestingly, we observed that several termini that were increased in both pretreatment conditions were chiefly extracellular proteins, suggesting that the majority of the observed proteolytic processes induced by cisplatin treatment occurred extracellularly ( Fig. 5F ). We also analyzed proteasome activity as chymotrypsin-like activity in the kidney cortex. There was no significant difference in proteasome activity between the samples ( Fig S6) . This suggests that the observed degradomic alterations are not part of a general, unspecific response regulating proteolytic protein decay, but rather part of specific extracellular proteolytic signaling processes.
Given the predominant increase extracellular processes ( S5 ).
Finally, we aimed to expand our dataset to unknown disease processes. Damage associated molecular patterns (DAMPs) have been suggested to correspond to acute cell death and tissue damage 32 . Therefore, we analyzed our proteomic dataset -which clearly reflects these damage processes -to determine novel patterns of protein-based DAMPs.
However, out of 72 known DAMPs compiled from the literature (Table S6, 33 . Using this strategy, we found that the Reactome pathway "Amyloid fiber formation" and especially the protein APCS, a circulating plasma protein suggested to be associated with binding of apoptotic cells and tubule formation in vitro 34, 35 , correlated most strongly with the degree of kidney damage (Fig. 7B ). The correlation on the mRNA level was much less prominent ( Fig. 7C ), and APCS was found to be only moderately increased on mRNA level ( Fig. S7A ). Consistently, accumulation and binding of APCS to tubule structures was also shown in immunohistochemical staining of cisplatin-treated kidneys while in vehicle treated kidney only diffuse background staining was shown ( Fig 7D) . Ultrasensitive mass spectrometry confirmed that APCS protein was found in both PAS positive tubules as well as PAS positive protein casts (2 of 2 identified peptides were unique) ( Fig. S7B , C).
Discussion.
Preconditioning-mediated protection from AKI holds the promise to reveal novel targets to prevent AKI in the clinical setting. In this study, we have shown the potential of two modes of preconditioning (CR and HP) in the prevention of cisplatin-induced AKI. Cisplatin induced a specific signature on protein abundance with an increased expression of known injury molecules and extracellular matrix components, and a decrease of specialized tubule epithelial proteins. Notably, both modes of preconditioning were strongly protective. CR ameliorated cisplatin-induced damage to an extent that made kidneys of these animals almost indistinguishable from healthy vehicle treated controls. One exception was the finding that kidneys from calorically restricted mice had a higher abundance of proteins promoting fatty acid synthesisa metabolic pathway that has interestingly already been linked to stress resistance in other models such as nematodes [36] [37] [38] . Analysis of glycerophospholipids revealed a loss of membrane lipids due to cisplatin treatment that is lower after CR. This suggests that loss of membrane integrity (likely induced by complement activation) is a key mechanism that is associated with cisplatin induced injury. In fact, this can be nearly abolished by endogenous fatty acid biosynthesis that is induced by CR ( Fig. 8 ).
This first multi-layered analysis of a proof-of-principle dataset of kidneys undergoing AKI revealed that a significant part of the damage response is probably not mediated on the transcriptional level but occurs post-transcriptionally. In fact, the dissociation of mRNA and proteome levels was strongly connected with the creatinine level in the individual animalwith a surprisingly high correlation coefficient (R > 0.95). Degradomics analyses revealed that motif-specific extracellular regulated protease activity is a significant contributor to the dissociation of mRNA and protein level. This included, for example, site-specific proteolytic activation and deposition of various complement cascade components converging in C3 activation that are comprehensively quantified within one mass spectrometry experiment.
Consistently with a disease-propagating role of this pathway, genetic ablation of complement C5 was shown to be protective in cisplatin-induced AKI, a finding partially attributed to induced release of the anaphylatoxin C5a 39 . A major role for extracellular signaling is also supported by bioinformatics analysis of DAMP-associated pathways. DAMPs are known to be involved in the intracellular regulation of cell death (such as the NFkappa B pathway, and the TGF related pathway) 32 . The most creatinine-correlated DAMPs term, however, was extracellular amyloid fiber formation, and serum amyloid P (APCS) was its most prominent component. APCS is suggested to bind to apoptotic cells, but has also been proposed to increase tubule formation and regeneration in vitro 34 . APCS deposition is also described to be inhibited by both HP 40 and CR 41 interventions in neurodegenerative diseases, suggesting an overarching mechanism controlling these aspects of tissue homeostasis. These data expand the commonly known and prominent role in chronic amyloidosis-like diseases of the kidney into this more acute setting.
In chronic kidney disease, extracellular matrix deposition and fibrosis determines decline of kidney function [42] [43] [44] [45] . In this model of cisplatin-induced AKI, the observed molecular changes occur rapidly and in the extracellular compartment. Notably, they are not reached by changing RNA abundance or production but rather protein quantity. Altogether, this is consistent with the hypothesis that the extent of cisplatin induced AKIas a variety of regulated cell death processes -is determined and maintained by "outside-in" signaling and the molecular composition of the extracellular microenvironment that mediates inflammatory processes 46, 47, 48 . Taking all the findings together one possible mechanism could be a complement induced lysis of cell membranes leading to an inflammatory microenvironment and cell death recruiting APCS by a release of calcium 49 . CR seems to prevent AKI by endogenous stabilization of cell membranes ( Fig. 8 ). Since APCS and other small molecules are also found in the tubule lumen, a contribution of endocytotic mechanisms to kidney damage cannot be excluded. Changes in glomerular filtration rate, going in line with AKI, have already been linked to fluid shear stress and a consecutive increase of endocytosis in proximal tubular cells 50, 51 and will require further investigation. In addition, a limitation of this study is that it yet does not distinguish between regenerative and detrimental pathways and the baseline omics landscape of the preconditioned kidney requires further investigation.
In conclusion, we provide an in depth multi-omic driven characterization of cisplatin induced kidney injury and preventive strategies that ameliorate renal damage. Although some of the pathways such as complement activation have been described in humans 52, 53 , the transferability of the findings in this proof-of-principle study to other models and, ultimately, human AKI, needs to be demonstrated. The obtained phenotype-driven computable datasets show that novel drug targets will ultimately have to block key microenvironmental shifts at a systems level, including extracellular protein deposition and proteolytic activity, in order to improve the outcome of AKI.
Methods
Animal procedures. The other section was fixed in 4% formaldehyde and subsequently embedded in paraffin.
Left kidneys were cut into two equal sections. One section was macroscopically divided into cortex and medulla for proteomic analysis. The other section was divided again into another two equal pieces. All parts of the left kidneys were snap frozen in liquid nitrogen for mRNAseq and N-degradome-analysis. Semiquantitative analysis of tubular damage of each kidney used for omic-analysis was performed by two different experienced nephropathologists in a blinded manner. A composite score to classify tubular damage was used as previously described 54 and the mean for each treatment group was plotted.
RNA isolation and sequencing
RNA isolation of total RNA was performed by using commercial homogenization (Bio 101 FastPrep FP120-120 V, Savant, Midland, MI, USA) and the RNeasy mini kit (Qiagen, Hilden, Germany). RNA sequencing was done by the Cologne Center for Genomics using the Ribo-Zero™Human/Mouse/Rat preparation kits and the Illumina®TruSeq®StrandedTotal RNASamples (Illumina, USA).
RNA-seq processing
Paired end total RNA-seq data was mapped to the mouse genome (mm10) using STAR aligner (v.2.5) with the default options and splice junction annotation from Ensembl (GRCm38.83). Count value for each gene was obtained using featureCount command from subread program (v.1.5) with the following options: paired end (-p) only considering primary alignment (--primary) and strand-specific for reverse forward protocol (-s 2; -S fr). For normalization, we used the transcript per millions (TPM) as defined by Li et al. 55 .
Reverse Transcription and Quantitative Real-time PCR (qPCR) Analysis
The already isolated RNA was used. 0.5 µg of total RNA was used as input. The cDNA synthesis was performed using the high-capacity-kit cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, USA). The cDNA products were further diluted 1:1 and used as qPCR templates in a triplicate experiment. qPCR was performed as previously described 56 
Sample preparation for proteomics analysis using LC-MS/MS.
Samples were prepared as previously described 57 . In brief, renal material was homogenized and sonicated in a buffer containing 8M urea, 100mM Ammonium bicarbonate, and protease inhibitor (roche). Samples were reduced with DTT and alkylated using IAA. Then, proteins were digested using trypsin at a 1:100 w/w ratio over-night. Then, peptides were cleaned up using stagetips 58 . Finally, nLC-MS/MS was performed on a QExactive plus (Thermo)
Orbitrap machine coupled to a nLC device (Proxeon) as previously described 59 . A 4h gradient was used for the separation of the peptides.
Laser capture dissection microscopy and tissue staining
Laser capture dissection microscopy was performed as previously described 60 . In brief, paraffin embedded tissue was cut into 10 µm slices and Periodic Acid Schiff-(PAS)-staining was performed. Afterwards, the selected regions were captured using a laser microdissection microscope (LMD7000, Leica, Wetzlar, Germany). Two areas in cisplatin injury were defined: 
Bioinformatic analysis of proteomic data.
Raw data were searched against a uniprot database (Jan 2017, reference proteome) and processed using MaxQuant v 1.5. with the LFQ (label-free quantification), iBAQ and match between runs option enabled. PSM, peptide and protein FDR were set as 0.01. Proteingroups output was further analyzed in R or in Perseus v 1.5.5.3 61 as previously described 56 .
In brief, contaminants and reverse hits, as well as proteins only identified by site were removed. Protein label-free quantification values were log 2 transformed and filtered for the presence of at least 3 valid values per treatment group. Significance cutoffs were determined using a permutation based false discovery rate (FDR) approach with fudge factor (parameters given in the figure legend) as previously described by Tusher et al. 62 . GO terms and uniprot keywords were annotated using the Perseus annotation package and were subsequently analyzed for overrepresentation using a Fisher's exact test with correction for multiple testing using Benjamini Hochberg FDR. Correlation coefficients were calculated in R and functional data were plotted in R-studio using the ggplot2 63 and cowplot packages.
Proteasome activity assay.
25 µg of renal cortex from 4 animals of each treatment group (veh/cis/HP/CR) were resuspended, as previously described 64 , with 50 l proteasome buffer. Subsequently, cytosolic extracts were generated by centrifugation at 14,000 g for 10 min at 4°C. After 
Integration of proteomics and transcriptomic data.
Data preprocessing: From the 16 different samples, the proteomic data obtained was expressed as intensity based absolute quantification (iBAQ), while on the transcriptomic dataset it was expressed as transcripts per millions (TPM). As a first step, all zeroes were regarded as missing values (NaN) and the remaining measurements were transformed as the log 2 of the original values. This was applied on both the proteomic and the transcriptomic datasets. Then, and only in the transcriptomic dataset, all values whose log 2 was below zero were also regarded as missing values, since they can be considered below the limit of quantification. Finally, we removed the genes or proteins which only had measurements in one of the conditions or which did not have measurements in the control group, as they were not usable in the differential expression analysis.
Data representation: All plots and data analysis were performed in R. For the t-Stochastic
Neighbor Embedding plots (t-SNE), we used the algorithm as implemented in the package Rtsne 66 as described by van der Maaten et al. 67 . The heatmaps and hierarchical clustering were obtained using the package pheatmap 68 . The remaining plots were generated by selfcoded functions using the standard library ggplot2 63 Differential expression analysis: For both the proteomic and transcriptomic datasets, the differential expression analysis compared the cisplatin treated groups (cis: only treated with cisplatin, HP: cisplatin and hypoxic preconditioning and CR: cisplatin and caloric restriction) against the control group. On each of the comparison groups, a linear model was fitted. Each fit followed the computation of the estimated coefficients and standard error of each gene or protein. Finally, the logodds, moderated t-and F-statistics of the differential expression were calculated using the empirical Bayes moderation of the standard errors towards a common value. The whole analysis was performed using the R package limma 69 .
Gene set analysis: When performing the gene set analysis (GSA), first we mapped all the genes and proteins to their related gene ontology (GO) terms by using UniProt web service 70 . With the t-values obtained from the differential expression analysis as gene set statistics, we ran the GSA using the Platform for Integrated Analysis of Omics data (piano) 71 . The analysis was performed using three different gene-level statistics, namely: mean, median and sum. From these, the consensus scores were extracted for the distinct-directional regulated genes/proteins using the same package. This enabled us to retrieve the most significant up-and down-regulated gene-sets (GO terms) of the different treatments with respect to the controls on both the transcript and protein levels.
Protein-transcript correlation analysis:
In order to compute the correlation between the transcriptomic and proteomic readouts, we first mapped the genes (as ENSEMBL gene IDs)
to the corresponding protein IDs (as UniProt AC). After removing genes with missing values, unmapped names and taking only the intersection between entries on both datasets, we obtained a list of 2510 elements. Then for each entry of the list, we computed the correlation between the protein and transcript levels across all the samples. Finally, to assess the significance of these correlations, we computed the corresponding p-values from the Zscores obtained by testing each correlation value against the whole distribution and also against a null-distribution (obtained by resampling the labels of the protein measurements 1000 times).
N-degradomic analysis and bioinformatics analysis
Enrichment and identification of protein N-termini: Proteins were extracted from renal cortex as described 30 . Enrichment of N-terminal peptides was performed by Terminal Amine Isotope Labeling of Substrates using different formaldehyde isotopes (12CH2O, 12CD2O
and 13CD2O) and sodium cyanoborohydride or sodium cyanoborodeuteride for modification and labeling of primary amines by triplex reductive dimethylation as described 72 to saturate the nitrogen gas stream with acetonitrile essentially as described 30 . Supplemental Table   S5 . Supplemental Tables. Table S1 : Proteomic analysis of in vivo alterations of renal damage.
Individual kidney cortices were subjected to preconditioning and cisplatin treatment and analyzed by LC-MS/MS. The excel file describes summarized results and comprehensive measurements for every individual animal of the initial study. The excel file describes transcriptomic expression values for every individual animal. N=4 for HP and n=3 for CR experiment. One experiment containing one set of animals was removed due to MS performance issues. 
